Cell proliferation in dimethylhydrazine-induced colonic adenocarcinomata following cytotoxic drug treatment.

作者: Peter J. M. Tutton , David H. Barkla

DOI: 10.1007/BF02889065

关键词:

摘要: A stathmokinetic technique was used to study cell proliferation in dimethylhydrazine-induced adenocarcinomata of rat colon following treatment with cytotoxic drugs. The rate division significantly increased three days after 5,7-dihydroxytryptamine and seven 5-fluorouracil. Acceleration tumour inhibited by treating animals the antiseritoninergic drug Xylamidine Tosylate. 5-fluorouracil either BW501 or histamine H2-receptor blocking Cimetidine.

参考文章(17)
P. J. M. Tutton, D. H. Barkla, Cell proliferation in the descending colon of dimethylhydrazine treated rats and in dimethylhydrazine induced adenocarcinomata Virchows Archiv B Cell Pathology. ,vol. 21, pp. 147- 160 ,(1976) , 10.1007/BF02899151
P. J. M. Tutton, D. H. Barkla, The influence of adrenoceptor activity on cell proliferation in colonic crypt ipithelium and in colonic adenocarcinomata. Virchows Archiv B Cell Pathology. ,vol. 24, pp. 139- 146 ,(1977) , 10.1007/BF02889274
Martin A. Adson, Richard J. Reitemeier, Charles G. Moertel, Advanced gastrointestinal cancer : clinical management and chemotherapy Hoeber Medical Division, Harper & Row. ,(1969)
P. J. M. Tutton, D. H. Barkla, The influence of serotonin on the mitotic rate in the colonic crypt epithelium and in colonic adenocarcinoma in rats. Clinical and Experimental Pharmacology and Physiology. ,vol. 5, pp. 91- 94 ,(1978) , 10.1111/J.1440-1681.1978.TB00657.X
Lyle A. Dethlefsen, Reba M. Riley, Hydroxyurea effects in the c3h mouse. I. Duodenal crypt cell kinetics. Cell Proliferation. ,vol. 6, pp. 3- 16 ,(1973) , 10.1111/J.1365-2184.1973.TB01590.X
Laurence H. Baker, Robert W. Talley, Richard Matter, Daniel E. Lehane, B. W. Ruffner, Stephen E. Jones, Francis S. Morrison, Ronald L. Stephens, Edmund A. Gehan, Vainutis K. Vaitkevicius, Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5‐FU vs. methyl‐CCNU plus bolus weekly 5‐FU. A southwest oncology group study Cancer. ,vol. 38, pp. 1- 7 ,(1976) , 10.1002/1097-0142(197607)38:1<1::AID-CNCR2820380102>3.0.CO;2-S